3D Molecular Designs prints 3D physical models of proteins and other molecular structures for biomedical researchers, and innovative educational models for educators.
Billion dollar deal for #psoriasis treatment: NDI-034858, a tyrosine kinase 2 () inhibitor developed by NimbusTx was bought by TakedaPharma. Congrats to our customer Nimbus for this milestone! See how they use Nanome 🖥️